A controlled study in humans reveals that coffee’s complex chemical matrix may shape immune responses differently than pure caffeine, highlighting how daily dietary exposures can subtly influence physiology.
Study: Immune modulation in response to coffee consumption: a pilot study. Image credit: ZeiMomArt/Shutterstock
In a recent study published in the European Journal of NutritionResearchers evaluated the acute immunological effects of coffee compared to an equivalent dose of caffeine in solution and water in healthy adults.
Coffee consumption and caffeine exposure are widely studied due to their potential metabolic and immunological effects, which affect quality of life and attract public health interest. Many people consume caffeine regularly and it is important to understand its physiological effects, while recognizing that changes in biomarkers do not necessarily translate into clinical health outcomes.
Dietary bioactive compounds, including caffeine and coffee polyphenols, have attracted attention due to their possible immunomodulatory effects. Caffeine is a methylxanthine found in coffee, acting in part through antagonism of adenosine receptors rather than serotonergic pathways. Unlike pharmaceutical interventions, coffee consumption represents a common dietary exposure rather than a clinical treatment, making its physiological impact relevant to everyday health research but not indicative of therapeutic effects.
The study and results
In the current study, researchers evaluated the acute effects of orally consumed coffee compared to an aqueous caffeine solution and water in healthy volunteers. This was a randomized crossover pilot study involving a small sample (n = 10). Participants were aged 20 to 40, regular coffee consumers, healthy and non-smokers, with a normal body mass index.
Individuals with chronic illness, medication use, pregnancy, or other health conditions affecting metabolism or immunity were excluded. Subjects received coffee, caffeine solution, or water containing an equivalent dose of caffeine (130 mg/100 ml) after a standardized meal to control postprandial metabolic effects.
In each phase of the study, participants received one of three drinks in random order with washout periods between sessions. The dose, approximately 130 mg of caffeine per serving, was consumed orally.
The primary outcome was postprandial immune response, including circulating cytokines and caffeine pharmacokinetics. Secondary measures included comparisons of inflammatory cytokines such as interferon gamma and interleukins, as well as caffeine exposure assessed by area under the curve. Safety monitoring included standard clinical observations appropriate for nutritional research.
Statistical analyzes involved repeated-measures comparisons of cytokine levels and caffeine pharmacokinetics between interventions.
Results
The study randomized 10 healthy participants to conditions of coffee, caffeine solution, and water. Participants were, on average, young adults and habitual coffee drinkers, with comparable baseline characteristics across interventions.
Immune marker responses differed slightly between interventions. Pure caffeine produced more pronounced suppression of some cytokines, including interferon gamma and some interleukins, while coffee often caused responses closer to water control despite having equivalent caffeine content.
Systemic caffeine exposure was higher after coffee consumption than after the caffeine solution, suggesting potential matrix effects from other coffee constituents that may influence absorption or metabolism, although the authors interpreted this cautiously, given the pilot-scale design.
Most physiological changes were acute and transient after beverage consumption, with no evidence of clinically significant adverse health effects or any indication of lasting immune alterations during the short observation period.
The intervention was well tolerated among participants who received coffee or other caffeinated beverages. No serious adverse events or clinically significant abnormalities were reported, although minor transient physiological responses, typical of caffeine consumption, were observed.
Conclusions
Acute consumption of coffee, which delivers approximately 130 mg of caffeine, produced measurable but modest immunological effects in healthy adults distinct from those observed with isolated caffeine, suggesting that non-caffeinated coffee components may alter physiological responses. The intervention appeared safe and well tolerated.
These results should be considered preliminary due to the small sample size, short-term design, and healthy participant population. Larger and longer studies involving diverse populations and habitual consumption patterns are needed to further evaluate the health implications of coffee and caffeine consumption.
